“Managing Bevacizumab-Related Gastrointestinal Perforation In Hepatocellular Carcinoma (HCC) Patients: A Systematic Review”, Rev Diabet Stud, pp. 1039–1048, Feb. 2025, doi: 10.70082/x94dvz94.